Mark Goldstone

Mark has over 25 years of experience in the healthcare industry, encompassing operations, commercialization and consulting. He has executed numerous M&A, financing and strategic partnership transactions, (from both sides of the fence), for a broad array of middle market and emerging growth companies in technology, life sciences and healthcare services. Mark has a passion for new technology, new “stuff” generally and all things creative.

Mark was the Worldwide President of DDB’s healthcare business, where he was responsible for a global communications business spanning 40+ offices in over 36 markets. The business covered advertising, digital, integrated communications, HCP promotion, branding, naming, design, market shaping, med ed and scientific communications.

Mark has previously held senior positions at Publicis Healthcare Communications Group where he was responsible for the global sanofi-aventis business and at Interbrand where he was CEO of their global Healthcare business.

Mark moved to New York where he held senior positions at Robert A. Becker, Euro RSCG and Jordan McGrath Case & Partners, Euro RSCG and ultimately at Euro RSCG Worldwide Headquarters, where he helped devise and build their global healthcare business – Euro RSCG Life Worldwide (Now Havas Life).

Mark holds a BSc (Hons) in Pharmacy. He is a board member of the prestigious Galien Foundation and a board member of G3 Global Genomics Group. He is a member of the Royal Pharmaceutical Society of Great Britain and is a past Co-Chairman of New York Corporate Development for the American Diabetes Association.